Northwestern scientists develop new drug that prevents spread of human prostate cancer cells in mice
A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells transplanted into mice from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the cancer cells and immobilizes them. The research was presented April 3 at the American Association for Cancer Research Annual Meeting 2012 in Chicago.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.